Correlation of serum B lymphocyte stimulator and β2 microglobulin with autoantibody secretion and systemic involvement in primary Sjogren's syndrome

被引:65
作者
Gottenberg, JE
Busson, M
Cohen-Solal, J
Lavie, F
Abbed, K
Kimberly, RP
Sibilia, J
Mariette, X
机构
[1] Hop Bicetre, Serv Rhumatol, INSERM, EMI 109, F-94275 Le Kremlin Bicetre, France
[2] Hop St Louis, APHP, INSERM, U396, Paris, France
[3] Hop Univ Strasbourg, Hop Hautepierre, Strasbourg, France
[4] Assistance Publ Hop Paris, Hop Bicetre, Le Kremlin Bicetre, France
[5] Univ Alabama Birmingham, Div Clin Immunol & Rheumatol, Birmingham, AL 35294 USA
关键词
D O I
10.1136/ard.2004.030643
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: In primary Sjogren's syndrome ( pSS), extraglandular involvement might result from more intense stimulation of autoreactive B cells. Thus markers of B cell activation could be useful in the clinical assessment of this disease. Objective: To investigate the association of serum B lymphocyte stimulator ( BLyS) and beta(2) microglobulin with autoantibody production and extraglandular involvement in pSS. Methods: Serum concentrations of BLyS and beta(2) microglobulin were analysed in 177 patients with pSS according to the American - European consensus group criteria. Serum beta(2) microglobulin was determined serially in 25 patients. Results: Autoantibody secretion ( presence of anti-SSA antibody alone or of both anti-SSA and anti-SSB) was associated with increased serum BLyS and beta(2) microglobulin. No correlation was found between BLyS and beta(2) microglobulin levels ( p = 0.36). Serum concentrations of beta(2) microglobulin and C reactive protein and positive anti-SSB antibody results were associated with extraglandular involvement on univariate analysis ( p< 10(-4), p = 0.003, and p = 0.004, respectively). Serum beta(2) microglobulin was also significantly increased in patients with extraglandular involvement without autoantibodies ( mean (SD): 1.75 (0.7) v 1.39 (0.5) mg/l, p = 0.039). Multivariate analysis showed that extraglandular involvement was associated only with increased serum beta(2) microglobulin ( p = 0.035, odds ratio = 2.78 (95% confidence interval, 1.07 to 7.22)). Among the 25 patients who had serial determinations of serum beta(2) microglobulin, the concentrations were increased in all those with disease flare and decreased in three following treatment. Serum BLyS, gamma globulin, IgG, and rheumatoid factor levels were not associated with features of systemic involvement. Conclusions: Serum beta(2) microglobulin and BLyS reflect B cell activation in different ways in pSS. Serum beta(2) microglobulin assessment could be helpful as an activity marker in pSS.
引用
收藏
页码:1050 / 1055
页数:6
相关论文
共 48 条
  • [1] SJOGRENS SYNDROME - ASSOCIATION OF ANTI-RO(SS-A) ANTIBODIES WITH VASCULITIS, HEMATOLOGIC ABNORMALITIES, AND SEROLOGIC HYPERREACTIVITY
    ALEXANDER, EL
    ARNETT, FC
    PROVOST, TT
    STEVENS, MB
    [J]. ANNALS OF INTERNAL MEDICINE, 1983, 98 (02) : 155 - 159
  • [2] Outcome measures in Sjogren's syndrome
    Asmussen, KH
    Bowman, SJ
    [J]. RHEUMATOLOGY, 2001, 40 (10) : 1085 - 1088
  • [3] BATAILLE R, 1984, BLOOD, V63, P468
  • [4] Reappraisal of serum β2-microglobulin as marker of GFR
    Bianchi, C
    Donadio, C
    Tramonti, G
    Consani, C
    Lorusso, P
    Rossi, G
    [J]. RENAL FAILURE, 2001, 23 (3-4) : 419 - 429
  • [5] STRUCTURE, FUNCTION, AND DIVERSITY OF CLASS-I MAJOR HISTOCOMPATIBILITY COMPLEX-MOLECULES
    BJORKMAN, PJ
    PARHAM, P
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 1990, 59 : 253 - 288
  • [6] THE DIAGNOSIS VALUE OF BETA-2-MICROGLOBULIN AND IMMUNOGLOBULINS IN PRIMARY SJOGRENS-SYNDROME
    BONGI, SM
    CAMPANA, G
    DAGATA, A
    PALERMO, C
    BIANUCCI, G
    [J]. CLINICAL RHEUMATOLOGY, 1995, 14 (02) : 151 - 156
  • [7] Collaborative research into outcome measures in Sjogren's syndrome - Update on disease assessment
    Bowman, SJ
    [J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2002, 31 : 23 - 27
  • [8] Salivary and serum β2-microglobulin and gamma-glutamyl-transferase in patients with primary Sjogren syndrome and Sjogren syndrome secondary to systemic lupus erythematosus
    Castro, J
    Jiménez-Alonso, J
    Sabio, JM
    Rivera-Cívico, F
    Martín-Armada, M
    Rodríguez, MA
    Jáimez, L
    Castillo, MJ
    Sánchez-Román, J
    [J]. CLINICA CHIMICA ACTA, 2003, 334 (1-2) : 225 - 231
  • [9] Cheema GS, 2001, ARTHRITIS RHEUM-US, V44, P1313, DOI 10.1002/1529-0131(200106)44:6<1313::AID-ART223>3.0.CO
  • [10] 2-S